Opioid Addiction

Featured Article

The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists

The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists

The guideline formulated by the Centers for Disease Control and Prevention in an effort to curb opioid overdose-related deaths included a recommendation for steep reductions in opioid doses for patients taking high doses of the drug for chronic pain.

Latest

Patterns of Non-Medical Prescription Opioid Use in Adolescents

Patterns of Non-Medical Prescription Opioid Use in Adolescents

The majority of adolescents taking prescription opioids for non-medical purposes were found to get these drugs from someone else.

Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You

Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You

Clinical Pain Advisor is seeking feedback on the FDA approval of Dsuvia for the management of acute pain.

Tools to Address the Opioid Crisis

Tools to Address the Opioid Crisis

The Stopping the Transmission of Opioids to the Next Generation tool allows clinicians treating women of childbearing age with opioid use disorder to estimate risks associated with pregnancies in this patient population.

Methamphetamine Use on the Rise in Patients With Opioid Use Disorder

Methamphetamine Use on the Rise in Patients With Opioid Use Disorder

The rate of past-month methamphetamine use was found to have significantly risen in individuals with opioid use disorder from 2011 to 2017.

Opioid Use May Be Associated With Difficulty Falling Asleep in Adults With Mild Chronic Pain

Opioid Use May Be Associated With Difficulty Falling Asleep in Adults With Mild Chronic Pain

Opioid use may be associated with more difficulty falling asleep in adults with low-intensity chronic pain.

Opioid Use Often Persists in Workers' Compensation Claimants

Opioid Use Often Persists in Workers' Compensation Claimants

Many patients in a workers' compensation cohort have persistent opioid use.

Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts

Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts

Clinical Pain Advisor is seeking feedback on the FDA approval of Dsuvia for the management of acute pain.

Nonopioid Lofexidine Safe and Effective for Managing Opioid Withdrawal Syndrome

Nonopioid Lofexidine Safe and Effective for Managing Opioid Withdrawal Syndrome

Lofexidine may expand the treatment options available for managing withdrawal when buprenorphine and methadone are unavailable or undesirable.

Bill to Fight U.S. Opioid Crisis Signed Into Law

Bill to Fight U.S. Opioid Crisis Signed Into Law

A bipartisan bill meant to combat the United States' opioid abuse epidemic was signed into law Oct. 24 by President Donald Trump.

Suboptimal Management of Patients Hospitalized for Injection Drug Use-Related Infections

Suboptimal Management of Patients Hospitalized for Injection Drug Use-Related Infections

Patients admitted to the hospital with an infection related to injection drug use were found to rarely be prescribed medication-assisted treatment, but instead were screened, received a brief intervention and a referral to treatment.

Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing

Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing

Receiving prescriptions from both the U.S. Department of Veterans Affairs (VA) and Medicare Part D is associated with increased risk for overlapping of opioid and benzodiazepine prescriptions.

Red Cross Releases Online Course on How to Respond to an Opioid Overdose

Red Cross Releases Online Course on How to Respond to an Opioid Overdose

The training has information on how to use several products including a nasal atomizer, Narcan Nasal Spray and Evzio.

Benefits of Increasing the Number of Buprenorphine-Waivered Physicians

Benefits of Increasing the Number of Buprenorphine-Waivered Physicians

Increasing the number of buprenorphine-waivered physicians may facilitate access to buprenorphine and contribute to reducing use of prescription opioids.

Set of Interventions May Effectively Reduce Opioid Overprescribing

Set of Interventions May Effectively Reduce Opioid Overprescribing

Interventions combining prescriber and patient education, a reduction in default amounts on opioid prescription orders, and increased oversight and accountability of individual prescribers may represent effective strategies for reducing opioid overprescribing.

What Do Clinicians Do in Response to Aberrant Urine Drug Test Results?

What Do Clinicians Do in Response to Aberrant Urine Drug Test Results?

After an aberrant urine drug test result in patients on opioid therapy, the majority of clinicians were found to change opioid dosing or enact another strategy to reduce opioid-related risks.

Educational Disabilities More Likely With Neonatal Abstinence Syndrome

Educational Disabilities More Likely With Neonatal Abstinence Syndrome

Children with a history of neonatal abstinence syndrome (NAS) are more likely to be referred for a disability evaluation and meet criteria for a disability.

Demographic Characteristics of Pregnant Women With Opioid Use Disorder

Demographic Characteristics of Pregnant Women With Opioid Use Disorder

A set of demographic, substance use, and treatment characteristics has been found to have a high prevalence in pregnant women with opioid use disorder.

Supervised Injection Sites: Facts, Information, Pros, and Cons

Supervised Injection Sites: Facts, Information, Pros, and Cons

Proponents of supervised injection sites argue they save lives. Critics say they discourage treatment. Where do you stand?

Medicaid Benefits for Addiction Treatment Expanded After ACA

Medicaid Benefits for Addiction Treatment Expanded After ACA

The Affordable Care Act may have prompted state Medicaid programs to expand addiction treatment benefits in alternative benefit plans.

Timely Receipt of Opioid Addiction Medication May Improve Youth Care Retention

Timely Receipt of Opioid Addiction Medication May Improve Youth Care Retention

In youths with opioid use disorder, treatment with buprenorphine, naltrexone, or methadone within 3 months of diagnosis was associated with greater care retention compared with behavioral therapy alone.